DexCom (DXCM) Tops Q4 EPS by 37c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall St set for lower open as AI jitters rekindle, oil gains
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- JPMorgan says AI stock selling may be nearing its limit as positioning resets
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
DexCom (DXCM) PT Raised to $175 at Cowen Following 4Q Report
February 22, 2019 6:43 AM ESTCowen analyst Doug Schenkel raised the price target on DexCom (NASDAQ: DXCM) to $175.00 (from $150.00) while maintaining a Outperform rating following the company's 4Q. Revenue of $338MM came in $53MM ahead of original consensus expectations and $7MM higher than pre-announced results. Gross margin of... More



